Single Lawsuit Filed in San Francisco for man with NSF
A complaint has been filed in the San Francisco Superior Court against Bayer Corp., General Electric Co., McKesson Corp. and other companies involved in the manufacturing and distribution of the contrast agent gadolinium used in MRIs. In this circumstance however, the firm is taking a case by case approach rather than a federal multi-district litigation (MDL) one. The plaintiff is a man with kidney disease who had the agent injected prior to an MRI and contracted the incurable disease Nephrogenic System Fibrosis. The victims’ lawyer says his client doesn’t have the kind of time it would take to fight in the MDL process and in fact hopes to invoke a California rule that puts cases involving a severely ill plaintiff on a track faster than normal. Further saying, that if his client is able to stay alive for the next 10 years, his treatment for NSF can be upwards of $10M in medical expenses.
